NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/13/2022
Back to search
Official data from USPTO
GO FURTHER ENDING AIDS & CERVICAL CANCER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
09/13/2022
Trademark type
Combined
Nice classes
35
Filing date
08/16/2021
Registration date
09/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2022
Last transaction
09/13/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/30/2019
First use in commerce
09/30/2019
Drawing code
3
Owner type
99
Owner location
Dallas, TX
Examiner
ZIMMERMAN, GAYNNE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of of the phrase "GO FURTHER ENDING AIDS & CERVICAL CANCER", wherein "GO" appears in a stylized lowercase red font in the upper left margin and the term "FURTHER" appears in a stylized lowercase turquoise script font to the right and slightly below the term "GO", with the letters "URTHER" being underscored by a stylized red horizontal underline, and with the terms "ENDING AIDS & CERVICAL CANCER" appearing in a smaller capitalized turquoise font immediately beneath said underline.
Holders and representatives
Holders
T. F. (pessoa física)
Representatives
ROBERT E. NAIL LOCKE LORD LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Global initiative funded by public and private investments to promote public awareness of the importance of prevention and the early detection of cervical cancer and to facilitate and increase access to cervical cancer screeningthe human papilloma virus (HPV) vaccine for prevention of cervical cancer and treatment for those most vulnerable to developing cervical cancerincluding among HIV-positive women in sub-Saharan Africa
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2022
DOCK
ASSIGNED TO EXAMINER
05/17/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2021
NWAP
NEW APPLICATION ENTERED
08/19/2021
Continuous trademark protection
Get notified about every new filing that threatens GO FURTHER ENDING AIDS & CERVICAL CANCER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.